Table 3.
Biomarker | Antigen | Capture antibody | Detection antibody |
---|---|---|---|
Growth/angiogenic factor | |||
VEGF | R&D System | R&D System | R&D System |
EGFR | R&D System | R&D System | R&D System |
Coagulation/thrombosis | |||
Hemoglobin | Sigma-Aldrich | Pierce | Pierce |
Adhesion | |||
ADAM8 | R&D System | R&D System | R&D System |
Beta-catenin | R&D System | R&D System | R&D System |
sICAM-1 | R&D System | R&D System | R&D System |
Inflammation | |||
COX2 | R&D System | R&D System | R&D System |
Pepsinogen | |||
Pepsinogen-I | R&D System | Abcam | Abcam |
Pepsinogen-II | Biohit | NOVUS | NOVUS |
Notes: R&D System: R&D System Inc., Minneapolis, MN, USA; Sigma-Aldrich: Sigma-Aldrich Co., St Louis, MO, USA; Pierce:; Biohit: Biohit, Helsinki, Finland; Abcam: Abcam, MA, USA; NOVUS: Novus Biologicals, Littleton, CO, USA.
Abbreviations: ICAM, intercellular cell adhesion molecule; VEGF, vascular endothelial growth factor; EGFR, epidermal growth factor receptor; ADAM8, A Disintegrin And Metalloproteinase domain-containing protein 8.